Embargo Policy

The embargo on all abstracts part of the 2017 Genitourinary Cancers Symposium will lift at 5:00 PM ET on Monday, February 13, 2017. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on February 13 for credentialed media.

Attend the Meeting in Person/Participate in the Presscast

Media registration for the 2017 Genitourinary Cancers Symposium is now open. To apply for media credentials,* register to attend an upcoming meeting, access embargoed meeting information, and locate presscast dial-in information, please visit ASCO's Media Headquarters. For questions about how to navigate the site, please contact ASCO Media Registration.

*If you attended the 2016 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the presscast. You only have to register if you want to attend the Symposium in Orlando.

Access Embargoed Information

Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.

Press Releases

  • 2017 Symposium Highlights Notable Research Advances in Genitourinary Cancers
    ORLANDO – Five studies exploring key issues in the treatment of genitourinary cancers will be presented at the 2017 Genitourinary Cancers Symposium, taking place February 16-18 at Rosen Shingle Creek in Orlando, Florida. Read the full release.
  • In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy
    ALEXANDRIA, Va. – A new retrospective analysis suggests that immunotherapy may be less effective in patients who receive antibiotics less than a month before starting treatment. Read the full release.
  • Some Patients Experience Long-Term Tumor Control Even After Stopping Immunotherapy Early
    ALEXANDRIA, Va. – Early findings from a new study appear to challenge the current standard practice for immune checkpoint inhibitor therapy – continuing treatment until cancer worsens. Read the full release.
  • Blood Test Uncovers Potential New Treatment Targets in Advanced Prostate Cancer
    ALEXANDRIA, Va. – Analysis of free-floating cancer DNA from blood samples has yielded leads for new prostate cancer treatment targets. Read the full release.
  • 2017 Genitourinary Cancers Symposium Press Program to Feature Research Advances in Prostate, Urothelial, Kidney Cancers
    ALEXANDRIA, Va. – Co-sponsors of the 2017 Genitourinary Cancers Symposium announced today three abstracts to be highlighted in the meeting’s official Press Program. Read the full release.

Presscast Recording

  • View a recording of the February 13 presscast, featuring three studies from the 2017 Genitourinary Cancers Symposium.

On-site Information for Media

Meet the News Planning Team

  • Sumanta Pal, MD
    City of Hope Comprehensive Cancer Center
    American Society of Clinical Oncology (ASCO)
  • Daniel Hamstra, MD, PhD
    The Texas Center for Proton Therapy
    American Society of Radiation Oncology (ASTRO)
  • Marc Dall'Era, MD
    UC Davis Comprehensive Cancer Center
    Society of Urologic Oncology (SUO)

Meeting Information

Media Resources

How Can We Help You?